Trial of BioGaia's Lactobacillus reuteri Protectis drops in infants with colic in China

Trial Profile

Trial of BioGaia's Lactobacillus reuteri Protectis drops in infants with colic in China

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Apr 2015

At a glance

  • Drugs Lactobacillus reuteri (Primary)
  • Indications Colic
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Apr 2015 New trial record
    • 27 Apr 2015 Results published online in Antonie van Leeuwenhoek on 16 Apr 2015, according to a BioGaia media release.
    • 27 Apr 2015 This study is the fifth positive colic study with Lactobacillus reuteri Protectis and the results confirm the positive results of earlier studies, according to a BioGaia media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top